| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.09 |